Daiichi Sankyo - M&A Summary and Business Overview

Life ScienceCompany

Daiichi Sankyo M&A Summary

Daiichi Sankyo has acquired 4 companies. A total of 3 acquisitions came from private equity firms. It has also divested 4 assets.

Daiichi Sankyo’s largest acquisition to date was in 2008, when it acquired Ranbaxy Laboratories for $5.5B. It’s largest disclosed sale occurred in 2014, when it sold Ranbaxy Laboratories to Sun Pharmaceuticals Industries for $4.0B. Daiichi Sankyo has acquired in 1 US state, and 3 countries. The Company’s most targeted sectors include life science (100%).

Daiichi Sankyo Business Overview

Where is Daiichi Sankyo headquartered?

Daiichi Sankyo is headquartered in Tokyo, Japan.

What is Daiichi Sankyo’s revenue?

Daiichi Sankyo disclosed revenue of 1,601,688M JPY for 2024 and 1,278,478M JPY for 2023.

How many employees does Daiichi Sankyo have?

Daiichi Sankyo has 18,726 employees.

What sector is Daiichi Sankyo in?

Daiichi Sankyo is a life science company.

When was Daiichi Sankyo founded?

Daiichi Sankyo was founded in 1899.

M&A Summary

  • M&A Total Activity8
    • M&A Buy Activity4
    • M&A Sell Activity4
  • Total Sectors Invested 1
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 6
  • M&A Advisors 2

Daiichi Sankyo

Daiichi Sankyo Co. Ltd.

3-5-1 Nihonbashi-Honcho Chuo-ku,
Tokyo, 103-8426
Japan,
+81 3 6225 1111
www.daiichisankyo.com

Daiichi Sankyo established through merger of Sankyo and Daiichi pharmaceutical. The Group manufactures pharmaceuticals for human/veterinary use and medical tools and equipment. It also researches and promotes products through related companies throughout the world. The Group also produces food, food additives, livestock feeds, and agrochemicals. Daiichi Sankyo was incorporated in 1899 and is based in Tokyo, Japan.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 4 - - - - - 4
vol $6.8B $6.8B
Sell (0.4/yr) # 2 1 - 1 - - 4
vol $4.0B $4.0B
  8

Most Recent M&A

Company Date Value Type
Daiichi Sankyo - Eight Branded Products 2022-01-18 - Divestiture
Tokyo, Japan
Daiichi Sankyo Altkirch Sarl 2020-04-01 - Divestiture
Altkirch, France
Daiichi Sankyo Co. Ltd. - Pharmaceutical Packaging Facility 2017-04-03 14M USD Divestiture
Bethlehem, Pennsylvania
Ambit Biosciences Corp. 2014-09-28 315M USD Add-on Acquisition
San Diego, California · www.ambitbio.com
Ranbaxy Laboratories Ltd. 2014-04-04 4.0B USD Divestiture
New Delhi, India · www.ranbaxy.com
Plexxikon, Inc. 2011-02-28 805M USD Add-on Acquisition
Berkeley, California · www.plexxikon.com
Ranbaxy Laboratories Ltd. 2008-06-11 5.5B USD Add-on Acquisition
New Delhi, India · www.ranbaxy.com
U3 Pharma AG 2008-05-21 234M USD Add-on Acquisition
Martinsried, Germany · www.u3pharma.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 4 (100%) 6.8B (100%) 3 (75%) 4.0B (100%)
Real Estate - - 1 (25%) 14M (< 1%)
Total 4 $6.8B 4 $4.0B

By Geo

State/Country Buy Value Sell Value
United States 2 1.1B 1 14M
  California 2 1.1B - -
  Pennsylvania - - 1 14M
India 1 5.5B 1 4.0B
France - - 1 -
Germany 1 234M - -
Japan - - 1 -
Domestic - - 1 (25%) -
Cross-border 4 (100%) 6.8B (100%) 3 (75%) 4.0B (100%)
Total 4 $6.8B 4 $4.0B

Top M&A Advisors

Financial Deals
Goldman Sachs
 1
Legal Deals
Simpson Thacher & Bartlett
 1

Deal Values

buy # Total
> $1B 1 $5.5B
$100M to $1B 3 $1.4B
TOTAL $6.8B
Largest Ranbaxy Laboratories Ltd.
$5.5B (2008-06-11)
sell # Total
> $1B 1 $4.0B
< $100M 1 $14M
TOTAL $4.0B
Largest Ranbaxy Laboratories Ltd.
$4.0B (2014-04-04)

M&A Connections

Deals
Acquired from
Investor(s)
75%
3 (75%)
Divested to
Strategic(s)
100%
4 (100%)

Company Summary

SECTOR

Life Science

Revenue

1,601,688   26% 2024
1,278,478   23% 2023
1,044,892   9% 2022
962,516   2% 2021
981,793   6% 2020
929,717   4% 2019
960,195   1% 2018
955,124   4% 2017
986,446   2016
(millions of JPY) Show More Show Less

Employees

18,726

Established

1899

Public

Tokyo (TSE): 4568

 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Daiichi Sankyo

Life Science Companies , Japan Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Japan Companies

Largest Japan Companies , Acquisitive Japan Companies , Recently Acquired Japan Companies , Recently Sold Japan Companies , Private Japan Companies , Public Japan Companies , Acquired Japan Companies , PE Backed Japan Companies
Mergr

Product

Company

Legal